All 692 (99.3%) study participants who had received at least one dose of a COVID-19 vaccine had detectable anti-S1-RBD-SARS-CoV-2 antibodies; the median titer was 13,891 AU/mL (IQR 8505–23,528 AU/mL). The gene discussed is PSMD1; the disease is COVID-19.